Fortress Biotech FBIOP
NASDAQ FBIOP
$18.30 +0.03 (+0.16%)
As of: Aug 21, 2026 · 3:33 PM EDT

Fortress Biotech, Inc. (FBIOP) Debt Ratio (2011 - 2026)

Fortress Biotech (FBIOP) posted quarterly Debt Ratio of 0.28 for Q4 2025, down 29.71% year-over-year from 0.4 in Q4 2024, and up 7.27% quarter-over-quarter from 0.26 in Q3 2025.

Fortress Biotech, Inc. (FBIOP) Debt Ratio (2011 - 2026) Analysis & Trends

Fortress Biotech's Debt Ratio history runs 15 years deep, the most recent figure standing at 0.28 for Q4 2025.

  • In Q4 2025, Debt Ratio fell 29.71% year-over-year to 0.28; the TTM figure through Dec 2025 stood at 0.28 (down 29.71% YoY), while the FY2025 annual figure was 0.28, down 29.71% from the prior year.
  • Debt Ratio for Q4 2025 stood at 0.28, up from 0.26 in the prior quarter.
  • The five-year high for Debt Ratio was 9.17 in Q2 2021, with the low at 0.1 in Q3 2021.
  • The 5-year median for Debt Ratio is 0.31 (2023), against an average of 0.73.
  • The sharpest annual moves came in 2021 and 2022: Debt Ratio surged 3738.29% in 2021, then sank 97.43% in 2022.
  • Fortress Biotech's Debt Ratio stood at 0.11 in 2021, then jumped by 187.83% to 0.31 in 2022, then climbed by 16.55% to 0.36 in 2023, then grew by 10.63% to 0.4 in 2024, then declined by 29.71% to 0.28 in 2025.
  • Business Quant data shows FBIOP's Debt Ratio at 0.28 in Q4 2025, 0.26 in Q3 2025, and 0.31 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 0.13
Dec 31, 2025 0.28
Sep 30, 2025 0.26
Jun 30, 2025 0.31
Mar 31, 2025 0.32
Dec 31, 2024 0.40
Sep 30, 2024 0.41
Jun 30, 2024 0.46
Mar 31, 2024 0.37
Dec 31, 2023 0.36
Sep 30, 2023 0.30
Jun 30, 2023 0.25
Mar 31, 2023 0.34
Dec 31, 2022 0.31
Sep 30, 2022 0.28
Jun 30, 2022 0.24
Mar 31, 2022 0.21
Dec 31, 2021 0.11
Sep 30, 2021 0.10
Jun 30, 2021 9.17